Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.71M | 1.71M | 1.46M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.71M | 1.71M | 1.46M | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.71M | 1.71M | 1.46M | -- | -- |
| SG&A Expenses | 5.52M | 4.89M | 5.09M | 4.04M | 5.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.54M | 10.05M | 10.00M | 7.26M | 10.51M |
| Operating Income | -8.83M | -8.34M | -8.54M | -7.26M | -10.51M |
| Income Before Tax | -8.42M | -8.02M | -9.07M | -7.91M | -11.22M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.42M | -8.02M | -9.07M | -7.91M | -11.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.03M | 982.00K | -1.23M | 2.50M | 4.53M |
| Net Income | -7.39M | -7.03M | -10.31M | -5.41M | -6.69M |
| EBIT | -8.83M | -8.34M | -8.54M | -7.26M | -10.51M |
| EBITDA | -8.68M | -8.18M | -8.35M | -7.03M | -10.27M |
| EPS Basic | -0.04 | -0.04 | -0.16 | -0.12 | -0.18 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.10 | -0.05 | -0.07 |
| EPS Diluted | -0.04 | -0.04 | -0.16 | -0.12 | -0.18 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.10 | -0.05 | -0.07 |
| Average Basic Shares Outstanding | 187.17M | 180.00M | 66.14M | 46.44M | 36.54M |
| Average Diluted Shares Outstanding | 187.17M | 180.00M | 66.14M | 46.44M | 36.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |